What Is Alzheimers

submitted by: ZekelHealthcare

By 2010 there will be one-half million patients per year. By 2050 that number will reach one million new patients per year. Globally, there are approximately 26 ½ million patients with Alzheimer’s disease that is roughly 1 in 8! Every 71 seconds today, someone in America develops Alzheimer’s disease!

Anesthesia and Incident Dementia

submitted by: WentzMR
Dr. Christopher Jankowski, an Assistant Professor of Anesthesiology from Mayo Clinic in Rochester, MN, shares study results appearing in the June 2013 issue of Mayo Clinic Proceedings. Utilizing data from the Rochester Epidemiology Project, the investigators found no correlation between dementia and exposure to anesthetic agents in older persons undergoing surgical procedures. Available at: http://tinyurl.com/btutmwe

High School Football and Risk of Neurodegeneration: A Community-Based Study

submitted by: WentzMR
Dr. Rodolfo Savica, Assistant Professor of Neurology at Mayo Clinic in Rochester, MN, discusses his article appearing in the April 2012 issue of Mayo Clinic Proceedings which finds no increased incidences of Dementia, ALS, or Parkinson's disease in persons who played high school football from the mid-1940's to the mid-1950's. Although this is excellent news for that population, further studies are needed to corroborate results in more recent high school sports participants, given the...

Exergaming and Older Adult Cognition: A Cluster Randomized Clinical Trial

submitted by: gowanc
Background: Dementia cases may reach 100 million by 2050. Interventions are sought to curb or prevent cognitive decline. Exercise yields cognitive benef?ts, but few older adults exercise. Virtual reality–enhanced exercise or “exergames” may elicit greater participation. Purpose: To test the following hypotheses: (1) stationary cycling with virtual reality tours (“cybercycle”) will enhance executive function and clinical status more than traditional exercise; (2) exercise...
Authors: Cay Anderson-Hanley, PhD, Paul Arciero

Effects of Comorbidity on NSTSEACS Mortality

submitted by: mcgheekkm
Dr. Juan Sanchis, a cardiologist at University Clinic Hospital in Valencia, Spain, summarizes his finding, published online first at www.mayoclinicproceedings.com http://tinyurl.com/4jpw78l and scheduled to appear in the April 2011 issue of Mayo Clinic Proceedings, that an index using the 5 comorbid conditions (renal dysfunction, dementia, peripheral artery disease, previous heart failure, and previous myocardial infarction) most associated with 1-year mortality in Non–ST-segment...

Neuropathic Pain Neurodegenerative Disease

submitted by: alex01

Dr. Remi Quirion (McGill University, Montreal, Quebec, Canada) described enhancement of the effects of pain-related peptides by PGE2 . This finding suggests a new, possible complimentary approach to the therapy of pain. Qurion also discussed anti-Alzheimer effect of polyphenols. This effect appears to be due not due to their antioxidant activity only. Quirion suggested the existence of membrane protein than binds polyphenols.

Alzheimer's Disease

submitted by: alex01
Z. Khachaturian, PhD. - New approaches to the therapy of Alzheimer’s disease (AD) are discussed in video interviews of this series. According to Z. Khachaturian (Potomac, MD) substantial progress has been made during the last 10 years in our understanding of pathogenesis of Alzheimer’s disease as well as in the discovery of biomarkers and therapeutic approaches. In addition to cholinergic drugs, inhibitors of plaque formation have been discovered, but the currently available...